Greg DiNoia's most recent trade in Mesa Laboratories, Inc. was a trade of 1,278 Common Stock done . Disclosure was reported to the exchange on June 17, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 1,278 | 4,189 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Sale of securities on an exchange or to another person at price $ 188.22 per share. | 17 Jun 2022 | 555 | 3,634 (0%) | 0% | 188.2 | 104,464 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 391 | 3,084 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 301 | 300 | - | - | Restricted Stock Units - 2 | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.57 per share. | 17 Jun 2022 | 173 | 2,911 (0%) | 0% | 185.6 | 32,104 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2022 | 90 | 90 | - | - | Restricted Stock Units - 1 | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commerical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 548 | 548 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Sale of securities on an exchange or to another person at price $ 323.72 per share. | 08 Nov 2021 | 280 | 2,693 (0%) | 0% | 323.7 | 90,642 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 3,223 | 6,694 | - | - | Non Qualified Stock Options | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,004 | 1,004 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 780 | 780 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commericial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 2,800 | 4,184 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commericial | Sale of securities on an exchange or to another person at price $ 255.67 per share. | 15 Jun 2021 | 1,211 | 2,973 (0%) | 0% | 255.7 | 309,616 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | 04 Jun 2021 | 540 | 5,914 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Sale of securities on an exchange or to another person at price $ 260.27 per share. | 04 Jun 2021 | 540 | 840 (0%) | 0% | 260.3 | 140,546 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.40 per share. | 04 Jun 2021 | 540 | 1,380 (0%) | 0% | 142.4 | 76,896 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commericial | Sale of securities on an exchange or to another person at price $ 276.75 per share. | 23 Feb 2021 | 280 | 840 (0%) | 0% | 276.8 | 77,490 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 02 Oct 2020 | 270 | 1,182 (0%) | 0% | 260 | 70,200 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | 02 Oct 2020 | 270 | 6,454 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.40 per share. | 02 Oct 2020 | 270 | 1,452 (0%) | 0% | 142.4 | 38,448 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 02 Oct 2020 | 62 | 1,120 (0%) | 0% | 260 | 16,120 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commerical | Sale of securities on an exchange or to another person at price $ 243.55 per share. | 04 Sep 2020 | 280 | 1,182 (0%) | 0% | 243.6 | 68,194 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Sale of securities on an exchange or to another person at price $ 245.70 per share. | 17 Aug 2020 | 835 | 1,462 (0%) | 0% | 245.7 | 205,160 | Common Stock |
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | 17 Aug 2020 | 783 | 6,724 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | Greg DiNoia | SVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 203.54 per share. | 17 Aug 2020 | 783 | 2,297 (0%) | 0% | 203.5 | 159,372 | Common Stock |